New evidence about risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain
We are proud to publish with national experts in infectious diseases and microbi [...]
Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020
We are proud to announce the release of the annual update of the "Report on Orph [...]
Alicia Gil, miembro de SWL
Como CEO de Omakase Consulting y profesional vinculada durante toda mi carrera a [...]
The February 2021 summary of P&R decisions in Spain is now available for downloading
The December 2020 summary of P&R decisions in Spain is now available for dow [...]
The Omakase community grows to 1000 followers!
Omakase is pleased to share we reached 1000 followers on LinkedIn! This is a mus [...]
Dr Poveda and Dr Badia tell us how to use the Orphan Drugs Horizon Scanning report in Spain
https://gacetamedica.com/politica/la-sefh-publica-la-segunda-revision-de-medicam [...]
We are proud to announce the release of Horizon Scanning 2020 where Omakase Consulting is working with Orphar-SEFH
https://twitter.com/sefh_/status/1363847789315301378?s=20 [...]
The December 2020 summary of P&R decisions in Spain is now available for downloading
The December 2020 summary of P&R decisions from the Spanish Interministerial [...]
52% of innovations approved in 2020 have some limitation in their prescription or dispensing
https://www.diariofarma.com/2021/02/09/el-52-de-las-innovaciones-aprobadas-en-20 [...]
CHMP positive opinions January 2021
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-product [...]